Loading clinical trials...
Loading clinical trials...
Dose cohorts may be dosed with one of up to 4 possible total weekly doses (0.3 mg, 1 mg, 2 mg, 4 mg). Dose escalation or repetition will be governed by pre-specified safety and activity rules. Subject...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Gilead Sciences
NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis
NCT07265544 · Liver Neoplasm, HBV Infection, and more
NCT02932150 · Chronic Hepatitis B
NCT07024641 · Hepatitis B Virus Infection
NCT07429864 · HBV, HBV Coinfection, and more
Mayo Clinic Hospital
Phoenix, Arizona
West Coast Clinical Trials, LLC
Costa Mesa, California
University of California Antiviral Research Center (AVRC)
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions